Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 350

    1.

    Elevations of AGE and vascular endothelial growth factor with decreased total antioxidant status in the vitreous fluid of diabetic patients with retinopathy.

    Yokoi M, Yamagishi SI, Takeuchi M, Ohgami K, Okamoto T, Saito W, Muramatsu M, Imaizumi T, Ohno S.

    Br J Ophthalmol. 2005 Jun;89(6):673-5.PMID: 15923499 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.

    Simó R, Lecube A, Segura RM, García Arumí J, Hernández C.

    Am J Ophthalmol. 2002 Sep;134(3):376-82.PMID: 12208249 [PubMed - indexed for MEDLINE]Related articles

    3.

    Relationship among VEGF, VEGF receptor, AGEs, and macrophages in proliferative diabetic retinopathy.

    Kakehashi A, Inoda S, Mameuda C, Kuroki M, Jono T, Nagai R, Horiuchi S, Kawakami M, Kanazawa Y.

    Diabetes Res Clin Pract. 2008 Mar;79(3):438-45. Epub 2007 Nov 28.PMID: 18053608 [PubMed - indexed for MEDLINE]Related articles

    4.

    Positive association of pigment epithelium-derived factor with total antioxidant capacity in the vitreous fluid of patients with proliferative diabetic retinopathy.

    Yokoi M, Yamagishi S, Saito A, Yoshida Y, Matsui T, Saito W, Hirose S, Ohgami K, Kase M, Ohno S.

    Br J Ophthalmol. 2007 Jul;91(7):885-7. Epub 2007 Feb 14.PMID: 17301120 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Regulation of angiogenesis in diabetic retinopathy: possible balance between vascular endothelial growth factor and endostatin.

    Noma H, Funatsu H, Yamashita H, Kitano S, Mishima HK, Hori S.

    Arch Ophthalmol. 2002 Aug;120(8):1075-80.PMID: 12149062 [PubMed - indexed for MEDLINE]Related articles

    6.

    Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.

    Watanabe D, Suzuma K, Suzuma I, Ohashi H, Ojima T, Kurimoto M, Murakami T, Kimura T, Takagi H.

    Am J Ophthalmol. 2005 Mar;139(3):476-81.PMID: 15767056 [PubMed - indexed for MEDLINE]Related articles

    7.

    Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.

    Matsunaga N, Chikaraishi Y, Izuta H, Ogata N, Shimazawa M, Matsumura M, Hara H.

    Ophthalmology. 2008 Nov;115(11):1916-22. Epub 2008 Aug 21.PMID: 18718666 [PubMed - indexed for MEDLINE]Related articles

    8.

    Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.

    Funatsu H, Yamashita H, Nakanishi Y, Hori S.

    Br J Ophthalmol. 2002 Mar;86(3):311-5.PMID: 11864890 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema.

    Funatsu H, Yamashita H, Nakamura S, Mimura T, Eguchi S, Noma H, Hori S.

    Ophthalmology. 2006 Feb;113(2):294-301. Epub 2006 Jan 10.PMID: 16406543 [PubMed - indexed for MEDLINE]Related articles

    10.

    Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy.

    Endo M, Yanagisawa K, Tsuchida K, Okamoto T, Matsushita T, Higuchi M, Matsuda A, Takeuchi M, Makita Z, Koike T.

    Horm Metab Res. 2001 May;33(5):317-22.PMID: 11440280 [PubMed - indexed for MEDLINE]Related articles

    11.

    Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

    Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, et al.

    N Engl J Med. 1994 Dec 1;331(22):1480-7.PMID: 7526212 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Stimulation and inhibition of angiogenesis in diabetic retinopathy.

    Funatsu H, Yamashita H, Noma H, Shimizu E, Yamashita T, Hori S.

    Jpn J Ophthalmol. 2001 Nov-Dec;45(6):577-84.PMID: 11754898 [PubMed - indexed for MEDLINE]Related articles

    13.

    Advanced glycation end products induce expression of vascular endothelial growth factor by retinal Muller cells.

    Hirata C, Nakano K, Nakamura N, Kitagawa Y, Shigeta H, Hasegawa G, Ogata M, Ikeda T, Sawa H, Nakamura K, Ienaga K, Obayashi H, Kondo M.

    Biochem Biophys Res Commun. 1997 Jul 30;236(3):712-5.PMID: 9245719 [PubMed - indexed for MEDLINE]Related articles

    14.

    Relationship between glycoxidation and cytokines in the vitreous of eyes with diabetic retinopathy.

    Matsumoto Y, Takahashi M, Ogata M.

    Jpn J Ophthalmol. 2002 Jul-Aug;46(4):406-12.PMID: 12225819 [PubMed - indexed for MEDLINE]Related articles

    15.

    Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients.

    Funatsu H, Yamashita H, Noma H, Mimura T, Nakamura S, Sakata K, Hori S.

    Graefes Arch Clin Exp Ophthalmol. 2005 Jan;243(1):3-8. Epub 2004 Jul 17.PMID: 15258777 [PubMed - indexed for MEDLINE]Related articles

    16.

    Intravitreous hepatocyte growth factor in patients with proliferative diabetic retinopathy: a case-control study.

    Simó R, Vidal MT, García-Arumí J, Carrasco E, García-Ramírez M, Segura RM, Hernández C.

    Diabetes Res Clin Pract. 2006 Jan;71(1):36-44. Epub 2005 Jul 18.PMID: 16029908 [PubMed - indexed for MEDLINE]Related articles

    17.

    Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study.

    Hernández C, Burgos R, Cantón A, García-Arumí J, Segura RM, Simó R.

    Diabetes Care. 2001 Mar;24(3):516-21.PMID: 11289478 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study.

    Fosmark DS, Bragadóttir R, Stene-Johansen I, Berg JP, Berg TJ, Lund T, Sandvik L, Hanssen KF.

    Acta Ophthalmol Scand. 2007 Sep;85(6):618-22. Epub 2007 May 4.PMID: 17488318 [PubMed - indexed for MEDLINE]Related articles

    19.

    Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.

    Ambati J, Chalam KV, Chawla DK, D'Angio CT, Guillet EG, Rose SJ, Vanderlinde RE, Ambati BK.

    Arch Ophthalmol. 1997 Sep;115(9):1161-6.PMID: 9298058 [PubMed - indexed for MEDLINE]Related articles

    20.

    Nitric oxide and vascular endothelial growth factor concentrations are increased but not related in vitreous fluid of patients with proliferative diabetic retinopathy.

    Hernández C, Lecube A, Segura RM, Sararols L, Simó R.

    Diabet Med. 2002 Aug;19(8):655-60.PMID: 12147146 [PubMed - indexed for MEDLINE]Related articles